Form 4: Telesis Bio Inc. Director James B. Weissman Acquires Shares and Stock Options

Director James B. Weissman acquired 8,390 shares of common stock and 5,268 stock options in Telesis Bio Inc. on July 24, 2024.

Summary

• On July 24, 2024, James B. Weissman, a director of Telesis Bio Inc., acquired 8,390 shares of common stock and 5,268 stock options.
• The common stock was acquired at a price of $0 per share.
• The stock options have an exercise price of $4.10.
• The restricted stock units (RSUs) vest over time, with one-third vesting annually from the grant date for 3,512 RSUs, and the remaining 4,878 RSUs vesting on January 1, 2025.
• The stock options vest monthly over three years from the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it simply reports the acquisition of shares and stock options by a director, which could be interpreted as a positive sign but doesn't provide enough information to be definitively positive.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedules for the RSUs and stock options indicate a long-term incentive plan for the director.

Industry Context

Form 4 filings are standard disclosures for insiders, providing transparency into their transactions in the company's securities.

Stakeholder Impact

• The acquisition of shares by a director may increase investor confidence.

Key Dates

Keywords

Telesis Bio Inc., James B. Weissman, Director, Stock Options, Common Stock, RSUs, Form 4, Acquisition, Vesting